GLYC - GlycoMimetics Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call Transcript

GlycoMimetics, Inc. (GLYC) Q3 2021 Earnings Conference Call November 02, 2021, 08:30 ET Company Participants Shari Annes - IR Harout Semerjian - CEO, President & Director Eric Feldman - SVP & Chief Medical Officer Brian Hahn - SVP & CFO Conference Call Participants Edward White - H.C. Wainwright & Co. Zegbeh Jallah - ROTH Capital Partners Jiale Song - Jefferies Presentation Operator Good morning, and thank you all for joining the GlycoMimetics call. [Operator Instructions]. I would now like to turn the call over to Ms. Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead. Shari Annes Good morning. Today, we will review our accomplishments and financial results for the period ended September 30, 2021. We'll also update you on recent achievements. The press release we issued this morning is available on the company's website at www.glycomimetics.com under the Investors tab. This call is being recorded. A

For further details see:

GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call Transcript